Skip to main content

Kisqali Prices, Coupons and Patient Assistance Programs

Kisqali (ribociclib) is a member of the CDK 4/6 inhibitors drug class and is commonly used for Breast Cancer, and Breast Cancer - Metastatic.

The cost for Kisqali oral tablet (200 mg (200 mg daily-dose)) is around $7,459 for a supply of 21 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Kisqali is available as a brand name drug only, a generic version is not yet available. View generic Kisqali availability for more details.

Kisqali prices

Oral Tablet

Quantity Per unit Price
21 $355.17 $7,458.54

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Quantity Per unit Price
42 (3 x 14 each) $354.94 $14,907.65

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Quantity Per unit Price
63 (3 x 21 each) $295.75 $18,632.19

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Kisqali Coupons, Copay Cards and Rebates

Kisqali offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Kisqali Novartis Oncology Universal Co-Pay Card

Eligible commercially insured patients may pay $25 per prescription with a maximum savings of $15,000 per calendar year; for additional information contact the program at 877-577-7756.

Applies to:
Kisqali
Number of uses:
per prescription per calendar year

Form more information phone: 877-577-7756 or Visit website

Kisqali 1 Free Treatment Cycle

Eligible patients may receive a 1-treatment cycle supply for free; for additional information contact the program at 800-282-7630.

Applies to:
Kisqali
Number of uses:
One-time offer

Form more information phone: 800-282-7630 or Visit website

Kisqali Femara Co-Pack 1 Free Treatment Cycle

Eligible patients may receive a 1-treatment cycle supply for free; for additional information contact the program at 800-282-7630.

Applies to:
Kisqali and Femara
Number of uses:
One-time offer

Form more information phone: 800-282-7630 or Visit website

Kisqali & Femara Novartis Oncology Universal Co-Pay Card

Eligible commercially insured patients may pay $25 per prescription with a maximum savings of $15,000 per calendar year; for additional information contact the program at 877-577-7756.

Applies to:
Kisqali and Femara
Number of uses:
per prescription per calendar year

Form more information phone: 877-577-7756 or Visit website

Kisqali 5-Treatment Cycle Access

Eligible commercially insured patients who are still waiting for coverage may be eligible for an additional supply of Kisqali that could continue for up to 5 treatment cycles; for additional information contact the program at 800-282-7630.

Applies to:
Kisqali
Number of uses:
Temporary Assistance

Form more information phone: 800-282-7630 or Visit website

Kisqali Femara 5-Treatment Cycle Access

Eligible commercially insured patients who are still waiting for coverage may be eligible for an additional supply of Kisqali that could continue for up to 5 treatment cycles; for additional information contact the program at 800-282-7630.

Applies to:
Kisqali and Femara
Number of uses:
Temporary Assistance

Form more information phone: 800-282-7630 or Visit website

Patient Assistance & Copay Programs for Kisqali

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Novartis Patient Assistance Foundation, Inc. (NPAF)

Eligibility requirements:
  1. Contact program for details.
  2. Based on FPL
  3. Not specified
  4. Must be residing in the US or US territory
  5. Novartis Oncology Products: To start the application process apply to PANO (Patient Assistance Now Oncology) at www.patient.novartisoncology.com or (800) 282-7630. Kesimpta: To start the application process apply to Alongside™ Kesimpta at www.Kesimpta.com or (855) 537-4678. Leqvio: To start the application process apply to Leqvio Service Center at www.Leqvio.com or (833) 537-8462. Mayzent: To start the application process apply to Alongside™ Mayzent at www.Mayzent.com or (877) 629-9368. All medication will be shipped directly to the patient, unless otherwise noted. Please contact the program for a complete product listing. www.pap.novartis.com
Applicable drugs:
  • Kisqali (ribociclib) Tablet
  • Kisqali and Femara (ribociclib-letrozole) Tablet; Co-Pack

More information please phone: 800-277-2254 Visit Website

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Kisqali (ribociclib) Tablet
  • Kisqali and Femara (ribociclib-letrozole) Tablet; Co-Pack

More information please phone: 866-316-7263 Visit Website

Provider: PANO (Novartis Patient Assistance Now Oncology)

Eligibility requirements:
  1. Determined case by case
  2. Not applicable
  3. Not specified
  4. The patient must reside in the US, Puerto Rico or the USVI.
  5. Eligibility determined on a case-by-case basis. Co-payment assistance, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Kisqali (ribociclib) Tablet
  • Kisqali and Femara (ribociclib-letrozole) Tablet; Co-Pack

More information please phone: 800-282-7630 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.